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Cancer cells grown in 3D under fluid 
flow exhibit an aggressive 
phenotype and reduced 
responsiveness to the anti‑cancer 
treatment doxorubicin
Tayebeh Azimi1, Marilena Loizidou2 & Miriam V. Dwek1*
3D laboratory models of cancer are designed to recapitulate the biochemical and biophysical 
characteristics of the tumour microenvironment and aim to enable studies of cancer, and new 
therapeutic modalities, in a physiologically‑relevant manner. We have developed an in vitro 3D model 
comprising a central high‑density mass of breast cancer cells surrounded by collagen type‑1 and we 
incorporated fluid flow and pressure. We noted significant changes in cancer cell behaviour using this 
system. MDA‑MB231 and SKBR3 breast cancer cells grown in 3D downregulated the proliferative 
marker Ki67 (P < 0.05) and exhibited decreased response to the chemotherapeutic agent doxorubicin 
(DOX) (P < 0.01). Mesenchymal markers snail and MMP14 were upregulated in cancer cells maintained 
in 3D (P < 0.001), cadherin‑11 was downregulated (P < 0.001) and HER2 increased (P < 0.05). Cells 
maintained in 3D under fluid flow exhibited a further reduction in response to DOX (P < 0.05); HER2 
and Ki67 levels were also attenuated. Fluid flow and pressure was associated with reduced cell 
viability and decreased expression levels of vimentin. In summary, aggressive cancer cell behaviour 
and reduced drug responsiveness was observed when breast cancer cells were maintained in 3D under 
fluid flow and pressure. These observations are relevant for future developments of 3D in vitro cancer 
models and organ‑on‑a‑chip initiatives.
The importance of the tumour microenvironment (TME) as a modulator of cancer cell behaviour is well recog-
nised and has led to the development of 3D in vitro models of cancer. This field has been driven by: (i) the need 
for laboratory models to enable interrogation of genetic, molecular and cellular events in real-time and (ii) the 
need for platforms to allow drug responses to be tested in a manner relevant to the clinic.
The TME comprises extracellular matrix (ECM) proteins and resident and infiltrating cells (for example 
fibroblasts, adipose, endothelial and immune cells) with physical features including capillary fluid flow and 
interstitial fluid pressure (IFP). The ECM, the major non-cellular component of the TME, comprises a complex 
mixture of macromolecules for example proteins, glycoproteins, proteoglycans and  polysaccharides1. By support-
ing and organising cellular structures, the ECM contributes to major cellular processes such as cell proliferation, 
survival, migration and  differentiation2 and interactions between cancer cells and the ECM results in alterations 
in response to anti-cancer  treatments3–5. The biophysical properties of the TME includes ECM stiffness, fluid 
shear stresses and IFP. These important characteristics influence tumour cell invasion and  metastasis6–8 and 
been shown to promote the migration of breast cancer cells grown in vitro in  3D9. Elevated IFP has been rec-
ognised as a tumour-associated phenomenon for several  decades10–12, associated with the resistance of cancer 
cells to treatment, expression of mesenchymal markers and the collective invasion of cancer  cells13–16. Recently 
microfluidic devices designed to enable the interplay between fluid flow and pressure and tumour cell behaviour 
have  emerged7.
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Triple-negative and HER2 positive breast cancers have the greatest rate of recurrence. In this study MDA-
MB231 cells, a triple negative breast cancer (TNBC) subtype, and SKBR3, a HER2 enriched breast cancer subtype, 
were used to study the effect of 3D cell culture on responsiveness to doxorubicin an anthracycline chemothera-
peutic agent which functions by intercalating DNA, inhibiting topoisomerase II and preventing DNA recombi-
nation. The aim was to evaluate, using a 3D model of breast cancer, the effect of increased fluid flow and IFP on 
cell proliferation, migration and sensitivity to doxorubicin.
Results
Cancer cells were prepared as a central dense cancer mass and nested in collagen type-1. This tumouroid was 
then housed in a Quasi-Vivo flow chamber with in-line Luer-lock valves designed to increase the IFP (Fig. 1).
Cell morphology and growth when cultured in 2D and 3D. When the cancer cells were grown as 
tumouroids in collagen by day 7 they started to aggregate and form clusters, Fig. 2. A switch to an epithelial 
phenotype was initially observed for the MDA-MB231 cells at day 1 but by day 3 these cells had regained their 
characteristic mixed mesenchymal/epithelial phenotype both within the centre of the cancer mass and at the 
invasive edge abutting the acellular stroma. SKBR3 cells retained their epithelial morphology in 3D throughout. 
When MDA-MB231 cells were grown as tumouroids and exposed to flow and pressure they exhibited 11-fold 
smaller cellular aggregates compared with cells maintained as static tumouroids, Fig. 2. The cellular aggregates 
formed by the SKBR3 cells were, however, of a similar size, irrespective of the 3D culture conditions.
The growth rate of MDA-MB231 and SKBR3 cells cultured as 3D tumouroids was compared with 2D mon-
olayer cultures using Alamar Blue reagent, Fig. 3. Fewer cells were seeded for the 2D culture (20,000 cells/well) 
compared to 3D culture (50,000 cells/tumouroid) due to limited space for attachment of cells in the 2D cultures. 
MDA-MB231 cells exhibited a reduced growth rate when cultured as tumouroids compared to 2D cell culture, 
and in flow and pressure conditions compared to static cell culture. The growth rate for SKBR3 cells propagated 
in 2D and tumouroids was similar until day 3, thereafter the growth rate of SKBR3 significantly reduced in the 
tumouroids. The same trend was observed when SKBR3 cells were grown as tumouroids under flow and pres-
sure compared to static conditions.
Proliferation, hypoxia, EMT, HER2 and apoptosis‑related gene expression. To investigate the 
molecular mechanism(s) underlying the decreased growth rates in the tumouroids the expression levels of genes 
for proliferation, hypoxia and apoptosis was assessed, Fig. 3. Comparing the 3D tumouroids with the 2D cul-
tures, the proliferation marker Ki67 was significantly downregulated and HIF1A was significantly upregulated in 
SKBR3 cells. Variable expression levels for caspase-3, caspase-9 and Bcl2 were observed when cells were grown 
Figure 1.  3D tumouroid flow system. (A) The experimental set-up housed in a laminar flow cabinet with 
Quasi-Vivo media reservoir, flow chamber and peristaltic pump. (B) Schematic view of the Quasi-Vivo fluid 
flow system with tumouroid housed inside the flow chamber, the peristaltic pump, flow restrictors, media 
reservoir, filter (0.22 µm) and direction of flow indicated.
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in 3D under flow and pressure. SKBR3 grown under 3D static conditions exhibited CASP3 levels that were 
Figure 2.  Cancer cells grown in 2D, 3D and 3D flow and pressure conditions. (A) MDA-MB231 and SKBR3 
tumouroids prepared in 3D collagen type-1 and visualised using an inverted light microscope 24 and 72 h after 
tumouroid formation. (B) The invasion of MDA-MB231 cells into the surrounding stroma in the tumouroid. 
(C) Cellular aggregates in tumouroids maintained under static and flow and pressure conditions for 7 days 
(SKBR3) and 14 days (MDA-MB231). (D) Montage created using tumouroids imaged with a ×2.5 objective 
of an Apo Tom 0.2 microscope. (E) Fold change difference in size of MDA-MB231 cell aggregates formed in 
tumouroids under static or flow and pressure conditions. Scale bars 100 µm unless otherwise stated.
Figure 3.  Cell viability and expression-levels for genes associated with apoptosis, proliferation and hypoxia 
for breast cancer cells maintained under different culture conditions. Upper panels: 2D monolayer culture and 
3D tumouroid. Lower panels: 3D tumouroids in static culture and under flow and pressure conditions. (A) 
Reduction of Alamar blue reagent, indicating higher metabolic activity/cell viability over time. (B) Expression-
levels of genes associated with apoptosis, hypoxia and proliferation in MDA-MB231 and SKBR3 cells. R = 2−ΔΔCT, 
i.e. fold change relative to 2D (upper panel) and static (lower panel). Mean average values ± SD (n = 3). Asterisks 
denote significant differences in gene expression, paired Student’s t-test; *P < 0.05; **P < 0.01; ***P < 0.001.
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not consistent with CASP9, this may reflect the inherent heterogeneity of the multi-clonal SKBR3 cancer cell 
line. Ki67 levels increased significantly when tumouroids were maintained under flow and pressure compared 
to static conditions; HIF1A levels remained unchanged; pro-apoptotic markers, caspase-3 and caspase-9 were 
upregulated whilst the anti-apoptotic marker Bcl2 was significantly downregulated.
Compared with 2D cell culture, tumouroids significantly upregulated both MMP14 and snail. Conversely, 
cadherin-11 expression levels decreased significantly and vimentin was unchanged, Fig. 4. When the tumouroids 
were grown under flow and pressure MMP14 was significantly upregulated whilst vimentin expression levels 
decreased significantly, and snail remained unaffected. Western blot analysis confirmed the results obtained 
with the qRT-PCR: there was no change in vimentin protein levels when MDA-MB231 cells were grown in 3D 
compared to 2D but a significant reduction in vimentin protein levels when tumouroids were maintained under 
flow and pressure. The antibody used recognises both the native and the phosphorylated forms of vimentin 
and the two bands observed on the western blots are consistent with the two isoforms of this protein, Fig. 4. 
Immunofluorescent microscopy confirmed the qRT-PCR and western blot results: cells grown in 2D and 3D 
had similar vimentin levels but this was reduced when cells were grown as tumouroids under flow and pressure.
HER2 is the target for therapy with monoclonal antibodies such as trastuzumab and pertuzumab. SKBR3 cells 
are enriched in HER2 and are often used in studies concerned with the cellular behaviour and drug responsive-
ness of this breast cancer subtype. HER2 was upregulated when cells were grown in 3D and further significantly 
increased when tumouroids were maintained under flow and pressure, Fig. 5.
Sensitivity to the anti‑cancer agent doxorubicin (DOX). MDA-MB231 and SKBR3 cells were treated 
with DOX and cell growth assessed using the Alamar Blue assay, Fig. 6. When grown as 2D monolayers MDA-
MB231 cells showed a significant decrease in viability following exposure to DOX (5 µM and 10 µM) and when 
grown in 3D were less sensitive to DOX. SKBR3 cells showed a significant decrease in viability when exposed 
to concentrations of ≥ 0.5 µM DOX in 2D and concentrations of ≥ 1 µM in 3D. Overall, both cell types showed 
reduced sensitivity to DOX when grown as 3D tumouroids compared to 2D culture. The application of flow and 
pressure to tumouroids further significantly reduced the cancer cell sensitivity to DOX.
Figure 4.  mRNA expression-levels for mesenchymal markers, immunofluorescent microscopy and western 
blot for vimentin in MDA-MB231 cells grown under different culture conditions. (A) Expression-levels of genes 
in MDA-MB231 cells. Upper panel: 2D monolayer culture and 3D tumouroid. Lower panel: 3D tumouroids 
in static culture and under flow and pressure conditions. R = 2−ΔΔCT calculated by subtracting ΔCT 2D culture 
(control) from ΔCT 3D collagen; and by subtracting ΔCT 3D static from ΔCT 3D flow and pressure. Mean 
average values ± SD (n = 3). Asterisks denote significant differences in gene expression, paired Student’s t-test; 
*P < 0.05; **P < 0.01; ***P < 0.001. (B) Immuno-fluorescent microscopy of MDA-MB231 cells stained with anti-
human vimentin (green). Upper panel: confocal microscopy of 2D monolayers, nuclei were counterstained with 
To-pro-3 (blue). Lower panels: fluorescence microscopy of cells in the centre and at the edge of the tumouroids 
after 14 days culture, nuclei were counterstained with DAPI. (C) Western blotting analysis of vimentin protein 
of MDA-MB231 cells grown under conditions as indicated. GAPDH was used as loading control.
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Discussion
In this study the growth and behaviour of breast cancer cells and sensitivity to DOX was investigated when cells 
were grown in 2D and 3D and under flow and pressure. Maintaining the cancer cells in 3D and in flow conditions 
resulted in a reduction in cell growth rates and also a reduction in the cancer cell sensitivity to DOX.
Collagen type-I has been widely used as a scaffold for 3D cell culture due to its physiological  abundance17. 
Most reports of 3D cancer cell culture experiments describe loose cancer cell aggregates with a high liquid-to-cell 
ratio. Such models do not reflect the cell density or the stiffness of the ECM observed in vivo for solid tumours. 
In this study the RAFT system (Lonza) was used, this utilises absorbers to remove excess liquid from the col-
lagen hydrogel resulting in a 40-fold increase collagen density. These 3D tumouroids therefore incorporate the 
mechanical forces of ~ 20 kPa found in tumours and exhibit oxygen levels equivalent to pathological  hypoxia17, 
this has led to these tumouroids being described as ‘physiological tissue mimics’ (Supplementary Figure S1).
To our knowledge, this is the first report in which 3D cancer cultures of defined stiffness have been main-
tained under flow and pressure conditions. MDA-MB231 and SKBR3 cells in 3D exhibited significantly lower 
rates of proliferation than 2D monolayer cultures. This observation is consistent with other studies, for example, 
HT29 colorectal cancer cells prepared in our laboratories using the same RAFT  system18. Similarly, it has been 
reported that U87, U251 and HS683 glioma cells cultured in 3D in collagen showed reduced growth rates over 
a 10 day period compared to 2D  culture19, this may reflect limited diffusion of nutrients from the media into 
the centre of the 3D constructs.
Epithelial-mesenchymal transition (EMT) is characterised by increased levels of snail, MMP14, cadherin-11 
and vimentin and is associated with cancer invasion and metastasis. EMT is induced as a result of the mechanical 
properties of the  ECM19–21. HT29 and HCT116 colorectal cancer cells grown as tumouroids in 3D culture in our 
laboratory have previously been shown to exhibit increased levels of  vimentin22. In this study, vimentin levels 
were unchanged when MDA-MB231 cells were maintained as tumouroids and the protein levels were signifi-
cantly decreased when cells were grown under flow and pressure. This finding does not concur with a report by 
Piotrowski-Daspit et al. where increased expression levels of vimentin in MDA-MB231 cells (cultured in 3D in 
collagen subjected to interstitial hypotension applied through hydrostatic fluid pressure) was  observed23. More 
work is required to understand the interplay between the TME and EMT when cancer cells are grown under 
Figure 5.  HER2 levels in SKBR3 cells grown under different culture conditions. (A) Expression-level of HER2. 
Upper panel: 2D monolayer culture and 3D tumouroid. Lower panel: 3D tumouroids in static culture and 
under flow and pressure conditions. R = 2−ΔΔCT calculated by subtracting ΔCT 2D culture (control) from ΔCT 
3D collagen; and by subtracting ΔCT 3D static from ΔCT 3D flow and pressure. Mean average values ± SD 
(n = 3). Asterisks denote significant differences in gene expression, paired Student’s t-test; *P < 0.05; **P < 0.01; 
***P < 0.001. (B) Immuno-fluorescent microscopy of SKBR3 cells stained with anti-human HER2 (green). Upper 
panel: confocal microscopy of 2D monolayers, nuclei were counterstained with To-pro-3 (blue). Lower panel: 
fluorescence microscopy of HER2 levels within cells maintained as 3D tumouroids.
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fluid flow and pressure. The increased levels of phosphorylated vimentin in MDA-MB231 cells maintained in 
3D suggests signal pathway activation.
Cancer cell invasion requires physical space within the ECM and the degradation of the ECM by enzymes 
such as the zinc dependent matrix metalloproteinases (MMPs) provides such space. Membrane bound MMP-14, 
for example, cleaves collagen type-I and other ECM  components24. MMP-14 expression levels was significantly 
upregulated when MDA-MB231 cells were grown in 3D under flow and pressure. A similar observation has 
been reported when mammary fibroblasts were grown in 3D (non-compressed) collagen scaffolds compared to 
2D monolayer  culture25 and when the normal breast epithelial cell line MCF-10A was grown in 3D on collagen 
type-126. A 3D model of ovarian cancer in which MMP14 was upregulated exhibited clustered β1-integrin at 
the cell  surface27, subsequent knock-down of β1-integrin in MCF-7 and MDA-MB231 breast cancer cells grown 
in 3D resulted in down-regulation of  MMP1428. This may represent a mechanism for induction of MMP-14 for 
the MDA-MB231 cells grown under flow and pressure described here.
Cadherin switching is also a feature of mesenchymal transition, it occurs through the action of snail and 
activation of associated cell signalling  pathways29,30. When snail was knocked down in MDA-MB231 reduced 
cellular invasion in vitro and decreased lymph node metastases in vivo was  reported31. 3D models of other epi-
thelial cancers cultured in collagen have shown increased expression levels of  snail32,33 mediated by TGF-β and 
downstream effector molecules. In the tumouroid model reported here snail expression levels were significantly 
increased when MDA-MB231 cells were grown in compressed collagen but remained unchanged under flow and 
pressure conditions. To date there have been limited reports on the effect of flow and pressure on mesenchymal 
markers in 3D models of cancer. Applying sheer stresses (1 dyne/cm2) via a 3D cell culture microfluidic device 
resulted in upregulation of α-SMA and snail and downregulation of VE-cadherin in human umbilical cord 
endothelial  cells34. Snail expression levels were similarly increased in MDA-MB231 cells grown as collagen scaf-
folds and under hypotensive conditions compared to static and other pressure  profiles23. In our study, the mRNA 
level for snail was increased when cells were maintained as 3D tumouroids but remained unaltered under flow 
and pressure conditions—this may reflect differences in the density of the collagen scaffold and flow pressure 
parameters applied in the different studies.
A significant reduction in cadherin-11 expression levels was observed when MDA-MB231 cells were grown 
as 3D tumouroids whilst cells grown as spheroids in ultra-low attachment plates showed significant upregula-
tion of cadherin-11 (data not shown). These findings are at odds with reports that invasive breast  tumours35 and 
cancer cells (MDA-MB231) metastatic to bone exhibit elevated levels of cadherin-1136.
Figure 6.  Sensitivity to doxorubicin of MDA-MB231 and SKBR3 cells were grown as monolayers and as 
tumouroids for 7 days. Cells were exposed to doxorubicin, at the concentrations shown, for 48 h. The cellular 
viability was measured using the Alamar blue assay. Mean average values ± SD (n = 3) are shown. Asterisks 
denote significant differences in cell viability, paired Student’s t-test; *P < 0.05; **P < 0.01; ***P < 0.001.
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Given the important role of 3D model systems as platform technologies in the oncology drug discovery 
pipeline it is imperative that the effect of culture conditions on cell membrane receptor levels are assessed, 
particularly as these are frequently the target for anti-cancer therapies. We observed an increase in HER2 levels 
when SKBR3 cells were grown in 3D and this was further attenuated under flow and pressure. Similarly, in a study 
using poly-HEMA coated plates, with an absence of ECM components, breast cancer cells BT474 and HCC1954 
exhibited elevated HER2 protein  levels37 and overexpression of HER2 was reported when the normal breast cell 
line MCF10A was maintained in agarose/Matrigel38. We observed spheroid-like aggregates when SKBR3 cells 
were grown as tumouroids and a significant increase in HER2 expression was observed when SKBR3 cells were 
grown as spheroids in ultra-low attachment plates without collagen (data not shown). These results indicate 
that the cell–cell interactions in 3D modulate HER2 levels and that increased HER2 levels do not arise from the 
interaction between cancer cells and the ECM alone.
3D cellular scaffolds, organoids and organ-on-a-chip models offer potential for drug discovery in oncology but 
the majority of in vitro 3D cancer models are usually free-floating or are made with soft hydrogels. Such systems 
do not mimic the physical properties of  tumours39. In this study we observed a significant decrease in the respon-
siveness of breast cancer cells to DOX treatment when cells were cultured as dense 3D tumouroids, compared 
to 2D monolayers, was well as when cells were grown under flow and pressure compared to static conditions. 
This reduced responsiveness may be due to decreased diffusion of drug through the dense matrix and through 
the cell  aggregates40, increased levels of HIF1A—indicative of hypoxic conditions within the  tumouroid41,42 and 
anti-apoptotic signals through integrin-mediated cell–matrix  adhesion43. Consistent with the results presented 
here, when the human ovarian cancer cell line OV-MZ-6 was grown as 3D spheroids a 50% increase in cell 
viability was observed (compared to monolayers) following treatment with  paclitaxel3. Resistance to cytotoxic 
drugs for example cisplatin or mitoxantrone has been reported in MCF-7 and MDA-MB231 cells grown in type-1 
collagen and β1-integrins play a key role in drug  resistance44. A recent report described increased resistance to 
the chemotherapeutic agents Ara-C and DNR of acute lymphoblastic leukemia (Jurkat) cells grown on scaffolds 
coated with type-I collagen and this was associated with the overexpression of discoidin domain receptor 5. When 
the cervical cancer cell line HeLa was maintained as spheroids a decreased sensitivity to DOX was observed com-
pared to cells grown in  2D45. MCF7 and MDA-MB231 breast cancer cells grown in PEG-fibrinogen hydrogels, 
housed in a microfluidic chip exhibited a decrease in response to paclitaxel and  DOX46.
In this report we provide a detailed understanding of breast cancer cell behaviour when the cells were main-
tained as 3D tumouroids under fluid flow. Recently other fluidic systems have become available for example 
PhysioMimix (CN-Bio, UK); Mimitas (Leiden, Netherlands); these ‘off-the-shelf ’ approaches augment bespoke 
systems developed in individual  laboratories47, alongside this the emergence of ‘tumour-on-a-chip’ technology 
in which fluid flow is integral continues  apace48. In these approaches it is important to ensure that the flow rates 
and shear forces delivered to the cancer cells are benchmarked against in vivo parameters. Concordance studies 
with different 3D cancer model systems under flow are now an important aim, the realisation of this will enable 
standardisation and adoption into the pharmaceutical drug development pipeline and is expected will result in 
reductions in the use of in vivo model  systems49–51.
This report is the first to describe a reproducible off-the-shelf approach in which cancer cells were prepared 
as a dense 3D mass surrounded by an acellular ECM, creating a tumouroid construct maintained under fluid 
flow and pressure. Exposing the tumouroids to physiological conditions of flow and pressure resulted in changes 
in their growth, morphology and sensitivity to chemotherapeutic challenge. This model system provides key 
evidence of the role of tissue density and fluid flow and is relevant to researchers using 3D models as cancer 
drug testing platforms.
Methods
All materials were supplied by Sigma-Aldrich, Poole, Dorset, UK unless otherwise stated.
Cell culture. MDA-MB231 (triple negative) and SKBR3 (HER2 positive) human breast adenocarcinoma 
cells were obtained from the ATCC. Cells were maintained in high glucose Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% v/v heat inactivated foetal bovine serum (FBS). 3D constructs “tumouroids”, 
comprising a central cancer mass embedded in a stromal compartment were manufactured using the RAFT 3D 
culture system (Lonza, UK) as described  previously22. Briefly, collagen type-I hydrogel was prepared by addition 
of 2.8 mL of minimal essential medium (10X MEM) to 22.4 mL rat-tail collagen type-I, 2 mg/mL (First Link, 
UK) and 1.624 mL neutralising solution (1.6 M NaOH in 840 mM HEPES buffer). In order to seed 50,000 cells in 
each well, 48 × 105 cells in 1.2 mL volume were added to the solution and mixed gently. 240 µL of the combined 
collagen-cell mixture was transferred to each well of a 96 well plate and incubated for 15 min at 37 °C allowing 
the hydrogel to set. RAFT absorbers were applied for 15 min to remove excess liquid thereby increasing the 
density of the collagen matrix. To create complex tumouroids, cancer masses were transferred into the centre of 
each well of a 24 well plate. Acellular stroma was added around the cancer mass and liquid was removed using 
RAFT absorbers, and the final product (100 µm thickness) was covered with media (DMEM plus FBS). This 
configuration enabled tumouroids to fit snugly inside flow chambers.
Fluid flow and pressure. To generate the flow environment the Quasi-Vivo system (Kirkstall, UK) was 
used. Tumouroids were nested in QV-500 polydimethylsiloxane chambers (biocompatible, transparent, flex-
ible, gas permeable silicone) and connected via inlet and outlet tubes in a ‘series’ configuration. A peristaltic 
pump was used to generate a pulsatile laminar unidirectional flow of media at various flow rates. A flow rate of 
550 µL/min, corresponding to an IFP of 0–3 mmHg consistent with normal breast tissue  IFP52 was used; whilst 
19 mmHg, consistent with breast tumour IFP was achieved by the addition of four one-way Luer check-valves, 
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biocompatible, female-male styrene acrylonitrile with silicone diaphragm, (Cole-Parmer, UK) in the middle of 
long outlet tube (Fig. 1).
Cell viability. Cell viability was assessed using the Alamar Blue assay (Thermofisher, UK) where the meta-
bolic activity of respiring cells reduces resazurin to resorufin. A 10% v/v solution of Alamar blue in phenol-red-
free and FBS-free media was added to the cells (2D or in 3D) and incubated for 4 h at 37 °C. Acellular wells (for 
3D culture, compressed collagen scaffolds without cancer cells) were used as controls. Absorbance values were 
measured using a microplate reader (BMG, Labtech, UK) at a wavelength of 570 nm and 600 nm and the per-
centage reduction of Alamar Blue reagent was calculated as per the manufacturer’s instructions.
Gene expression analysis. Expression levels of Ki67, Bcl2, caspase-3, caspase-9, HIF1A, vimentin, snail, 
MMP14, cadherin-11 and HER2 genes involved in proliferation, apoptosis, hypoxia and EMT was analysed 
using qRT-PCR. Total RNA was extracted using an RNeasy Micro kit (Qiagen, Germany) according to the man-
ufacturer’s instructions. The quantity and purity of RNA was assessed using a Nanodrop spectrophotometer 
(Thermofisher Scientific, USA) at 260/280 nm and RNA integrity assessed by agarose gel electrophoresis. Com-
plementary DNA (cDNA) was prepared using the QuantiTect Reverse Transcription Kit (Qiagen, Germany) 
according to the manufacturer’s instructions. To ensure that no genomic DNA remained in the extracted RNA, 
sample were prepared omitting the reverse transcriptase from the cDNA production process. Similarly, samples 
without addition of cDNA were used in the qRT-PCR assay. Primer efficiency (linearity) was assessed prior 
to undertaking the sample analysis and qRT-PCR reactions prepared using the Quanti-Nova SYBR Green kit 
(Qiagen, Germany) following the manufacturer’s instructions. A Rotor Gene real-time cycler (BioRad, UK) was 
used with 40 cycles of the following cycling conditions: denaturation 5 s at 95 °C, combined annealing/extension 
10 s at 60 °C. The sequences of the forward and reverse primers for the genes studied in this project were as fol-
lows: Bcl2 forward 5′ TCG CCC TGT GGA TGA CTG A 3′, reverse 5′ CAG AGA CAG CCA GGA GAA ATCA 3′; cas-
pase-3 forward 5′ CAG CAA ACC TCA GGG AAA C 3′, reverse 5′ TCA CCC AAC CAC CCT GGT CTT 3′; caspase-9 
forward 5′ GCT CTT CCT TTG TTC ATC TCC 3′, Reverse 5′ GCT GCT TGC CTG TTA GTT C 3′; HIF1A forward, 
5′ CGT TCC TTC GAT CAG TTG TCThe 3′, reverse 5′ TCA GTG GTG GCA GTG GTA GT 3′; vimentin forward, 5′ 
AGA TGG CCC TTG ACA TTG AG 3′, reverse 5′ CCA GAG GGA GTG AAT CCA GA 3′; snail forward, 5′ TTT CTG 
GTT CTG TGT CCT CTG CCT 3′ reverse, 5′ TGA GTC TGT CAG CCT TTG TCC TGT 3′; MMP14 forward, 5′ ATA 
AAC CCA AAA ACC CCA CC, reverse 5′ AAA CAC CCA ATG CTT GTC TC 3′; CDH11 forward, 5′ CCC AGT ACA 
CGT TGA TGC CT 3′, reverse 5′ GAC GTT CCC ACA TTG GAC CT 3′; Ki67 forward 5′ CCA CAC TGT GTC GTC 
GTT TG 3′, reverse 5′ CCG TGC GCT TAT CCA TTC A 3′; HER2 forward 5′ AAC TGC ACC CAC TCC TGT GT 3′, 
reverse 5′ TGA TGA GGA TCC CAA AGA CC 3′. Reference gene: GAPDH forward 5′ GAC AGT CAG CCG CAT 
CTT CT 3′, reverse 5′ TTA AAA GCA GCC CTG GTG AC 3′. The expression level of reference gene GAPDH was 
used as an endogenous control gene for all the samples.
Protein analysis. Vimentin and HER2 protein levels were assessed using immunostaining and western 
blotting.
Immunostaining. Cancer cells grown in 2D were evaluated for levels of vimentin and HER2 proteins as 
described  previously22,53. First, tumouroids were washed with PBS and fixed with 10% v/v formaldehyde. They 
were permeabilised using 1% w/v BSA with 0.2% v/v Triton-100 in PBS at room temperature for 1 h and washed 
with PBS three times for 5  min prior to immunostaining. Rabbit monoclonal vimentin antibody applied at 
dilution of 1:100 (#5741, Cell Signalling Technology,) and rabbit monoclonal anti-ErbB 2 antibody (ab134182, 
Abcam) at dilution of 1:250 in 1% w/v BSA with 0.2% v/v Triton-100 in PBS and incubated at 4 °C overnight 
followed by 1 h incubation at room temperature and washing in PBS as above. The secondary antibody, goat 
anti-rabbit IgG, Alexa Fluor 488 (Abcam) was diluted in 1% w/v BSA with 0.2% v/v Triton-100 in PBS at dilution 
of 1:500 and incubated with the tumouroids for 2.5 h at room temperature and washed in PBS as above. Finally, 
the nuclei were counterstained using DAPI and cells were imaged using an Apo Tom 0.2 fluorescent microscope 
(Zeiss, Germany).
Western blotting. Cancer cells cultured as 2D monolayers were harvested using trypsin–EDTA and the 
cells pelleted using standard tissue culture techniques. Cells cultured as 3D tumouroids in 24-well plates were 
pre-treated with 200 units/mL collagenase I (Gibco, UK) in HBSS buffer (450 µL per well) for 60 min on a plate 
shaker at 37 °C, centrifuged at 1,700×g for 5 min and the cell pellet collected. SDS PAGE and western blotting 
was performed using the cell pellets as described previously 18. The resulting blots were incubated with rabbit 
monoclonal anti-vimentin antibody (Cell Signalling Technology, USA) at 1:100 and rabbit monoclonal anti-
ErbB 2 antibody (ab134182, Abcam, UK) at 1:1,000. Rabbit polyclonal anti-GAPDH antibody (Abcam, UK) 
was used as loading control on the same blot at 1:5,000 for 90 min. Goat polyclonal anti-rabbit IgG (HRP) pre-
adsorbed (Abcam, UK) was used as secondary antibody at 1:5,000 for 60 min. The resulting blot was visualised 
using enhanced chemiluminescence (ECL) detection system (Thermofisher, USA) by adding a mixture of equal 
parts of peroxide solution and the luminol/enhancer solution on the blot and incubate it for 5 min. The images 
were captured using a Biospectrum UVP imaging system following 20 and 60 s exposure times.
Doxorubicin (DOX) treatment. The sensitivity of cancer cells to DOX was assessed by measuring the cell 
viability using the Alamar Blue assay. For 3D culture, 5 × 104 cells were seeded in each tumouroid for both cell 
lines. Cells were allowed to grow for a week, the media was removed and DMEM with 2% v/v FBS was added 
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for 24 h. Cells were then incubated with DOX at 0.1 µM, 0.5 µM, 1 µM, 5 µM and 10 µM diluted in serum-free 
DMEM. Control wells contained medium alone. For the tumouroids prepared under flow conditions replicate 
experiments (n = 2 per condition) were prepared either in static cell culture or with IFP ± 5 µM DOX for 48 h. 
All tumouroids were transferred to 24 well plates and the Alamar blue assay was performed as described above.
Statistical analysis. Statistical analysis was performed using OriginPro software from OriginLab Cor-
poration, MA, USA. The data was analysed for normality and then evaluated using a paired Student’s t-test. 
P-value ≤ 0.05 were considered statistically significant.
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